Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors
Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors
Recruiting · NCT06950086 · Registry updated 2025-04-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors | HR-positive, HER2-negative Advanced Breast Cancer | Recruiting | Phase 1 / Phase 2 | 2025-04-29 | NCT06950086 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| TYK Medicines, Inc | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 85 |